about
State of the evidence: mechanical ventilation with PEEP in patients with cardiogenic shockImaging the immune response to monitor tumor immunotherapy.Combination strategies in myelodysplastic syndromes.More is better: combination therapies for myelodysplastic syndromes.The safety and efficacy of nivolumab for the treatment of advanced renal cell carcinoma.Clinical Effect of Dose Escalation After Disease Progression in Patients With Metastatic Renal Cell Carcinoma.Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy.Dying revisited: understanding the process, six years later.Screening for functional kinases in metastatic prostate cancer: a glimmer of hope for kinase inhibition.Emerging immunotherapy in advanced renal cell carcinoma.The Evolving Treatment Landscape of Advanced Renal Cell Carcinoma in Patients Progressing after VEGF Inhibition.A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma.A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapyTailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC)
P50
Q26863373-7912C7BB-696E-4A61-9BC8-B7E31966E829Q37608319-D7C8646E-01DB-43BC-99CF-983956411847Q37973280-BA806024-5C2A-4F67-B98B-A860D3C1C366Q38346885-006E76C1-CFAC-48C8-8A54-665BA4F9BA0FQ38825250-BDB44148-0A7E-4D64-B526-56BA36712788Q39393942-90A960A2-39A5-4200-99DF-69735FD2F6D5Q41560706-6C8186E4-8834-4B17-86CA-433EBC85EB46Q44670821-8578370B-9CAC-44B0-9908-690D0860417BQ46065800-CC853566-1A7B-45AD-B7F1-C8E2006C7BF9Q47956257-4F9B9D2A-5ADA-4E61-95C9-5126B43C3C91Q53153700-EB7C70AF-F053-48B7-A85F-708431E99AF1Q53531674-6D76C6D1-6A1E-4605-9919-7CAC4CAD5CBEQ64053624-CCA4FCBB-C8EC-42A7-86B0-72B0CA270591Q91691745-6743C1B6-1059-46C0-8452-F5DA4ACD5F42
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Moshe C Ornstein
@ast
Moshe C Ornstein
@en
Moshe C Ornstein
@es
Moshe C Ornstein
@nl
type
label
Moshe C Ornstein
@ast
Moshe C Ornstein
@en
Moshe C Ornstein
@es
Moshe C Ornstein
@nl
prefLabel
Moshe C Ornstein
@ast
Moshe C Ornstein
@en
Moshe C Ornstein
@es
Moshe C Ornstein
@nl
P106
P31
P496
0000-0003-0184-3467